Literature DB >> 21983848

Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?

Nur Canpolat1, Salim Caliskan, Lale Sever, Alper Guzeltas, Fatih Kantarci, Cengiz Candan, Mahmut Civilibal, Ozgur Kasapcopur, Nil Arisoy.   

Abstract

A total of 66 children and adolescents with chronic kidney disease (CKD) (20 pre-dialysis patients and 46 chronic dialysis patients) were evaluated to address the prevalence of abnormalities in glucose and insulin metabolism and their association with cardiovascular disease. Glucose intolerance was assessed using an oral glucose tolerance test; insulin resistance was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR). Carotid artery intima-media thickness (IMT) and left ventricular hypertrophy (LVH) were examined as early markers of cardiovascular disease. Thirty-four patients (7 pre-dialysis, 27 dialysis) exhibited an abnormal glucose tolerance; however, ten patients (7 pre-dialysis, 3 dialysis) were insulin-resistant. Height-specific standard deviation scores of carotid artery IMT were above normal in three of the pre-dialysis patients (15%) and in 34 of the dialysis patients (74%). LVH was present in seven pre-dialysis (35%) and 34 dialysis patients (74%). In addition, two of the pre-dialysis patients (10%) and 18 of the dialysis patients (39%) had severe LVH. The prevalence of both increased carotid artery IMT and LVH were similar in patients with or without glucose intolerance in both groups, but severe LVH was more prevalent in pre-dialysis patients with glucose intolerance (p = 0.042). The multivariate analyses showed that neither carotid artery IMT nor LVM index was predicted by serum glucose levels or HOMA-IR. In conclusion, children with CKD are at a high risk of glucose intolerance and also have a greater risk of subclinical cardiovascular disease (CVD). However, the presence of glucose intolerance does not appear to be an independent risk factor for increased carotid artery IMT or LVH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983848     DOI: 10.1007/s00467-011-2034-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  50 in total

1.  Impaired fasting glucose is not a risk factor for atherosclerosis.

Authors:  M Hanefeld; T Temelkova-Kurktschiev; F Schaper; E Henkel; G Siegert; C Koehler
Journal:  Diabet Med       Date:  1999-03       Impact factor: 4.359

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 3.  Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review.

Authors:  G Brohall; A Odén; B Fagerberg
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

4.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

5.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

6.  Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Authors:  Elizabeth L M Barr; Paul Z Zimmet; Timothy A Welborn; Damien Jolley; Dianna J Magliano; David W Dunstan; Adrian J Cameron; Terry Dwyer; Hugh R Taylor; Andrew M Tonkin; Tien Y Wong; John McNeil; Jonathan E Shaw
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

7.  Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Rudolph A Rodriguez; Michael H Humphreys
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  Glucose intolerance in children with chronic renal failure.

Authors:  R H Mak; G B Haycock; C Chantler
Journal:  Kidney Int Suppl       Date:  1983-11       Impact factor: 10.545

10.  Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Authors:  Tilman Drüeke; Véronique Witko-Sarsat; Ziad Massy; Béatrice Descamps-Latscha; Alain P Guerin; Sylvain J Marchais; Valérie Gausson; Gérard M London
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  5 in total

1.  Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Priyanka Khandelwal; Vijaya Murugan; Smriti Hari; Ramakrishnan Lakshmy; Aditi Sinha; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2016-02-26       Impact factor: 3.714

2.  Carotid intima media thickness, oxidative stress, and inflammation in children with chronic kidney disease.

Authors:  Juan Antonio Garcia-Bello; Rita A Gómez-Díaz; Alicia Contreras-Rodríguez; Juan O Talavera; Rafael Mondragón-González; Lorena Sanchez-Barbosa; Margarita Diaz-Flores; Adan Valladares-Salgado; Juan Manuel Gallardo; Alejandra Aguilar-Kitsu; Jesus Lagunas-Munoz; Niels H Wacher
Journal:  Pediatr Nephrol       Date:  2014-02       Impact factor: 3.714

3.  Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease.

Authors:  Ylva Tranæus Lindblad; Jonas Axelsson; Rita Balzano; Georgios Vavilis; Milan Chromek; Gianni Celsi; Peter Bárány
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

4.  Cardiovascular risks in chronic kidney disease pediatric patients.

Authors:  Jing Tian; Ling Niu; Xinjiang An
Journal:  Exp Ther Med       Date:  2017-09-15       Impact factor: 2.447

5.  Cardiovascular risk in children and adolescents with end stage renal disease.

Authors:  Maria Luiza do Val; Fernanda Souza Menezes; Henrique Tsuha Massaoka; Valeska Tavares Scavarda; Adriano Czapkowski; Heitor Pons Leite; Valdir Ambrósio Moises; Sergio Aron Ajzen; João Tomas de Abreu Carvalhaes; José Osmar Medina Pestana; Paulo Koch-Nogueira
Journal:  Clinics (Sao Paulo)       Date:  2019-06-19       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.